Precision Decisions in NDMM: A Live Virtual Rounds Preview

The therapeutic landscape for newly diagnosed multiple myeloma (NDMM) is expanding rapidly, offering better outcomes alongside distinct management challenges. In this Live Virtual Rounds previews, expert faculty shares critical insights into the modern multidisciplinary approach to NDMM. Learn more about the Live Virtual Rounds here: https://oncdata.com/ndmm-live-virtual-rounds-preview Session 1 - July 8 at 6:00 pm EST: https://bit.ly/3QWrgD5 Session 2 - July 28 at 7:00 pm EST: https://bit.ly/4ahPmi5 What You’ll Learn in This Episode: 🔹 Nuanced Treatment Selection: How disease-related features and patient logs dictate modern frontline choices over a "one-size-fits-all" model. 🔹 Proactive Patient Care: Essential strategies to stay ahead of insurance barriers, steroid side effects, and adherence issues during induction. 🔹 Sustainable Treatment Goals: Recognizing why delivering a sustainable, tolerated dose is often more clinically effective than chasing maximum trial-level doses in real-world settings. Chapter Timestamps: About the Speaker: Ashley Chen, PharmD, BCOP, is a Clinical Pharmacist in Malignant Hematology/Oncology at Fred Hutchinson Cancer Center and the University of Washington. She is deeply involved in clinical research, safe medication use practices, and the development of institutional clinical practice guidelines. Stay Connected: Subscribe for more deep dives into oncology research and practice. Website: https://oncdata.com/ Follow us on X/Twitter: @OncData Timestamps 00:00 – Introduction: Navigating NDMM Therapeutic Advances 00:55 – Interview: Dr. Ashley Chen on the Evolving Pharmacist Role 02:00 – Managing Nuances: Quadruplets and Shifting Transplant Landscapes 03:15 – Solving Medication Burden and Steroid Toxicities in Induction 04:30 – Case for Individualized, Sustainable Dosing for Frail Patients 05:40 – What to Expect from i3 Health's Upcoming Live Virtual Rounds 06:35 – Wrap-up & Links to Full Coverage